Literature DB >> 7935390

Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression.

G L Robinson1, S R Cordle, E Henderson, P A Weil, G Teitelman, R Stein.   

Abstract

Pancreatic beta-cell-type-specific transcription of the insulin gene is principally regulated by a single cis-acting DNA sequence element, termed the insulin control element (ICE), which is found within the 5'-flanking region of the gene. The ICE activator is a heteromeric complex composed of an islet alpha/beta-cell-specific factor associated with the ubiquitously distributed E2A-encoded proteins (E12, E47, and E2-5). We describe the isolation and characterization of a cDNA for a protein present in alpha and beta cells, termed INSAF for insulin activator factor, which binds to and activates ICE-mediated expression. INSAF was isolated from a human insulinoma cDNA library. Transfection experiments demonstrated that INSAF activates ICE expression in insulin-expressing cells but not in non-insulin-expressing cells. Cotransfection experiments showed that activation by INSAF was inhibited by Id, a negative regulator of basic helix-loop-helix (bHLH) protein function. INSAF was also shown to associate in vitro with the bHLH protein E12. In addition, affinity-purified INSAF antiserum abolished the formation of the activator-specific ICE-binding complex. Immunohistochemical studies indicate that INSAF is restricted in terms of its expression pattern, in that INSAF appears to be detected only within the nuclei of islet pancreatic alpha and beta cells. All of these data are consistent with the proposal that INSAF is either part of the ICE activator or is antigenically related to the specific activator required for insulin gene transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935390      PMCID: PMC359201          DOI: 10.1128/mcb.14.10.6704-6714.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Insulin gene expression in nonexpressing cells appears to be regulated by multiple distinct negative-acting control elements.

Authors:  S R Cordle; J Whelan; E Henderson; H Masuoka; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

3.  Novel insulin promoter- and enhancer-binding proteins that discriminate between pancreatic alpha- and beta-cells.

Authors:  H Ohlsson; S Thor; T Edlund
Journal:  Mol Endocrinol       Date:  1991-07

4.  Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene.

Authors:  S Y Shieh; M J Tsai
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

5.  TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.

Authors:  H Beckmann; L K Su; T Kadesch
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

6.  Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.

Authors:  M S German; M A Blanar; C Nelson; L G Moss; W J Rutter
Journal:  Mol Endocrinol       Date:  1991-02

7.  Effect of 5'-flanking sequence deletions on expression of the human insulin gene in transgenic mice.

Authors:  M Fromont-Racine; D Bucchini; O Madsen; P Desbois; S Linde; J H Nielsen; C Saulnier; M A Ripoche; J Jami; R Pictet
Journal:  Mol Endocrinol       Date:  1990-05

8.  Cooperativity of sequence elements mediates tissue specificity of the rat insulin II gene.

Authors:  Y P Hwung; Y Z Gu; M J Tsai
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

Review 9.  The myoD gene family: nodal point during specification of the muscle cell lineage.

Authors:  H Weintraub; R Davis; S Tapscott; M Thayer; M Krause; R Benezra; T K Blackwell; D Turner; R Rupp; S Hollenberg
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

10.  Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins.

Authors:  S R Cordle; E Henderson; H Masuoka; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

View more
  6 in total

1.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

2.  Functional characterization of the transactivation properties of the PDX-1 homeodomain protein.

Authors:  M Peshavaria; E Henderson; A Sharma; C V Wright; R Stein
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

3.  The insulin enhancer binding site 2 (IEB2; FAR) box of the insulin gene regulatory region binds at least three factors that can be distinguished by their DNA binding characteristics.

Authors:  M L Read; S B Smith; K Docherty
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site.

Authors:  P Serup; H V Petersen; E E Pedersen; H Edlund; J Leonard; J S Petersen; L I Larsson; O D Madsen
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

5.  c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products.

Authors:  G L Robinson; E Henderson; M E Massari; C Murre; R Stein
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Redox-sensitive up-regulation of eNOS by purple grape juice in endothelial cells: role of PI3-kinase/Akt, p38 MAPK, JNK, FoxO1 and FoxO3a.

Authors:  Mahmoud Alhosin; Eric Anselm; Sherzad Rashid; Jong Hun Kim; Socorro Vanesca Frota Madeira; Christian Bronner; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.